Mylan N.V.:企業の戦略・SWOT・財務情報

◆英語タイトル:Mylan N.V. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4440
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Mylan N.V. – Strategy, SWOT and Corporate Finance Report
Summary

Mylan N.V. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Mylan N.V. (Mylan or ‘the company’) is a pharmaceutical products company which develops, licenses, manufactures, markets and distributes generic, branded and over-the-counter (OTC) products in a variety of dosage forms and therapeutic categories. The company sells its products to retail pharmacy chains, wholesalers and distributors, group purchasing organizations, drug store chains, independent pharmacies, drug manufacturers, institutions, and public and governmental agencies and markets these products across North America, Europe and other regions worldwide. Mylan is headquartered in Hatfield, Hertfordshire, the UK.

Scope

- Detailed information on Mylan N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Mylan N.V. in the form of a SWOT analysis
- An in-depth view of the business model of Mylan N.V. including a breakdown and examination of key business segments
- Intelligence on Mylan N.V.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Mylan N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Mylan N.V. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Mylan N.V. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Mylan N.V.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Mylan N.V.: Company Overview 9
Mylan N.V.: Overview and Key Facts 9
Mylan N.V.: Overview 9
Mylan N.V.: Key Facts 9
Mylan N.V.: Key Employees 11
Mylan N.V.: Key Employee Biographies 12
Mylan N.V.: Major Products and Services 17
Mylan N.V.: Company History 18
Mylan N.V.: Management Statement 26
Mylan N.V.: Locations and Subsidiaries 28
Mylan N.V.: Key Competitors 30
Mylan N.V.: Company Analysis 31
Mylan N.V.: Business Description 31
Mylan N.V.: SWOT Analysis 33
Mylan N.V.: SWOT Overview 33
Mylan N.V.: Strengths 33
Mylan N.V.: Weaknesses 34
Mylan N.V.: Opportunities 35
Mylan N.V.: Threats 36
Mylan N.V.: Corporate Financial Deals Activity 38
Mylan N.V.: Financial Deals Overview 38
Mylan N.V.: Targets and Partners 40
Mylan N.V.: Top Deals 2014 – 2018YTD* 41
Mylan N.V.: Advisors 42
Mylan N.V.: Top Legal Advisors 42
Mylan N.V.: Top Financial Advisors 42
Mylan N.V.: Mergers and Acquisitions 43
Mylan N.V.: Capital Raising 44
Mylan N.V.: Partnership 45
Mylan N.V.: Divestments 46
Mylan N.V.: Recent Developments 47
Mylan N.V.: News and Events Summary 47
Mylan N.V.: Business Expansion 50
Mylan N.V.: Corporate Governance 50
Mylan N.V.: Financial Deals 50
Mylan N.V.: Financial Performance 51
Mylan N.V.: Market Developments 51
Mylan N.V.: Red Flags/DistressSignals 53
Mylan N.V.: Regulatory and Legal Events 53
Appendix 55
Contact Us 55
Methodology 55
About MarketLine 56

List of Tables
Table 1: Mylan N.V.: Key Facts
Table 2: Mylan N.V.: Key Employees
Table 3: Mylan N.V.: Locations and Subsidiaries
Table 4: Mylan N.V.: Key Competitors
Table 5: Mylan N.V.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Mylan N.V.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Mylan N.V.: M&A Average Deal Size - Value (US$m)
Table 8: Mylan N.V.: Targets and Partners
Table 9: Mylan N.V.: Top Deals 2014 - 2018YTD*
Table 10: Mylan N.V.: Legal Advisor Ranking by Value (US$m)
Table 11: Mylan N.V.: Financial Advisor Ranking by Value (US$m)
Table 12: Mylan N.V.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Mylan N.V.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Mylan N.V.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 15: Mylan N.V.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 16: Mylan N.V.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 17: Mylan N.V.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 18: Mylan N.V.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 19: Mylan N.V.: News and Events Summary
Table 20: Mylan N.V.: Business Expansion
Table 21: Mylan N.V.: Corporate Governance
Table 22: Mylan N.V.: Financial Deals
Table 23: Mylan N.V.: Financial Performance
Table 24: Mylan N.V.: Market Developments
Table 25: Mylan N.V.: Red Flags/DistressSignals
Table 26: Mylan N.V.: Regulatory and Legal Events

List of Figures
Figure 1: Mylan N.V.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Mylan N.V.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Mylan N.V.: M&A Average Deal Size - Value (US$m)
Figure 4: Mylan N.V.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Mylan N.V.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Mylan N.V.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 7: Mylan N.V.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 8: Mylan N.V.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 9: Mylan N.V.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 10: Mylan N.V.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Mylan N.V.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hrvatski Telekom d.d. (HT-R-A):企業の財務・戦略的SWOT分析
    Hrvatski Telekom d.d. (HT-R-A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Tejas Networks Ltd (TEJASNET):企業の財務・戦略的SWOT分析
    Tejas Networks Ltd (TEJASNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Gunvor Group Limited:石油・ガス:M&Aディール及び事業提携情報
    Summary Gunvor Group Limited (Gunvor) is a vertically integrated energy trading company. It is one of the global traders of physical crude oil; refined products and energy; and metals and bulk materials. The company provides integrated trading products and logistics service to connect upstream suppl …
  • MBDA Holdings SAS:企業の戦略・SWOT・財務情報
    MBDA Holdings SAS - Strategy, SWOT and Corporate Finance Report Summary MBDA Holdings SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Barkan Wine Cellars Ltd:企業の戦略的SWOT分析
    Barkan Wine Cellars Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Enlivant Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Enlivant Inc (Enlivant) is an assisted living facilities provider that offers senior living residence services. The center provides senior housing options, choosing assisted living and short term stay services. It also provides attentive and individualized care services. Enlivant offers assi …
  • Walsin Lihwa Corporation:企業の戦略・SWOT・財務情報
    Walsin Lihwa Corporation - Strategy, SWOT and Corporate Finance Report Summary Walsin Lihwa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Rosenergoatom Concern:企業の戦略的SWOT分析
    Rosenergoatom Concern - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Sangetsu Corporation (8130):企業の財務・戦略的SWOT分析
    Sangetsu Corporation (8130) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • BBA Aviation plc (BBA):企業の財務・戦略的SWOT分析
    BBA Aviation plc (BBA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • TIBCO Software, Inc.:企業のM&A・事業提携・投資動向
    TIBCO Software, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TIBCO Software, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Desitin Arzneimittel GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Desitin Arzneimittel GmbH (Desitin), formerly Desitin Compagnie mbH is a healthcare products provider that offers therapeutic products. The company develops and markets products for the treatment of neurological and psychiatric illnesses. It provides products for various therapeutic areas su …
  • Allied Technologies Limited:企業のM&A・事業提携・投資動向
    Allied Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Allied Technologies Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • RegenxBio Inc (RGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary RegenxBio Inc (RegenxBio), formerly ReGenX Biosciences LLC is a provider of therapeutics for various diseases. The company develops, commercializes and licenses recombinant adeno-associated virus (AAV) gene therapy. Its products include AAV plasmids, AAV vector reporter systems and custom AA …
  • AltheaDx Inc:医療機器:M&Aディール及び事業提携情報
    Summary AltheaDx Inc (AltheaDx) is a molecular diagnostics company that offers development of pharmacogenetics. The company provides tests such as cardiovascular tests, pain tests, thrombophilia tests and psychiatric tests. It provides diagnostic development, clinical trial and discovery services. A …
  • Shanghai Kinetic Medical Co Ltd (300326):医療機器:M&Aディール及び事業提携情報
    Summary Shanghai Kinetic Medical Co Ltd (KMC) is a medical device company. The company’s product categories include orthopaedics, ENT products, and vascular surgery products. Its orthopaedic products comprise wire anchor, cervical anterior nail plate system, vertebral dilatation ballon catheter, bon …
  • Viking Therapeutics Inc (VKTX):企業の財務・戦略的SWOT分析
    Summary Viking Therapeutics Inc (Viking Therapeutics) is a clinical-stage biopharmaceutical company that develops novel therapies for patients suffering from metabolic and endocrine disorders. Its lead clinical program product candidate include VK5211, an orally available, non-steroidal selective an …
  • The York Water Co (YORW):企業の財務・戦略的SWOT分析
    The York Water Co (YORW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Meritor, Inc. (MTOR):企業の財務・戦略的SWOT分析
    Meritor, Inc. (MTOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Asahi Kasei Corp (3407):企業の財務・戦略的SWOT分析
    Asahi Kasei Corp (3407) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆